Article:
Retinoblastoma: ten years experience at kanti children's hospital

creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorSah, Kailash Prasad
dc.contributor.authorSaiju, Rohit
dc.contributor.authorRoy, Pankaj
dc.contributor.authorKafle, Sonali
dc.creator.affiliationKanti Children’s Hospital, Nepal.
dc.creator.affiliationTilganga Eye Hospital, Kathmandu, Nepal.
dc.creator.affiliationKanti Children’s Hospital, Nepal.
dc.creator.affiliationKanti Children’s Hospital, Nepal.
dc.date.accessioned2026-10-12T06:29:55Z
dc.date.available2026-10-12T06:29:55Z
dc.date.issued2013
dc.description.abstractAbstract Introduction: Retinoblastoma is a malignant tumor of the embryonic neural retina. It is the most common intraocular tumor of childhood. It is a disease of early childhood with 80% cases diagnosed before the age of 4 years. The median age at diagnosis is 2 years. Bilateral cases are diagnosed earlier (median at 12 months and unilateral median age at 24 months). The incidence of retinoblastoma is approximately 1 in 15000-18000 live births in developed countries. The aim of the research is to study the clinical pathological features, treatment and survival of children with retinoblastoma over ten years. Methods: A retrospective hospital based study was conducted from March 1998 to February 2008. Gender, age, clinical presentation, pathology reports, treatment, follow –up and outcome were recorded at time of diagnosis. Results: A total of 42 children with retinoblastoma (85.7 % unilateral, 14.3% bilateral), with 50% having optic nerve involvement were studied. The most common presenting signs were extraoccular (28.6%), proptosis (23.8%), leukoria (23.8%), phthisis bulbi (16.7%), and strabismus (7.1%). The age at presentation ranged from 6-120 months with mean age of 46.6 months. The male to female ratio was 1.1:1.Two-thirds presented between 2-5 yrs, followed by 12-24 months (23.8%). Majority of children had poorly differentiated retinoblastoma (62 %), followed by well differentiated (28.6%), and moderately differentiated (9.5%). CEV based protocol used to treat, and over-all 10 yrs survival was 23.8 %, death 19 %, and lost to follow-up or left against medical advice 57.2%. Conclusions: Despite severe resource limitation, pediatric oncology unit has been successfully treating retinoblastoma with the success rate of 23.8%. Keywords: Chemotherapy; Outcome; Remission; Retinoblastoma.
dc.identifier.doihttps://doi.org/10.31729/jnma.2429
dc.identifier.urihttps://hdl.handle.net/20.500.14572/8100
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.subjectChemotherapy
dc.subjectOutcome
dc.subjectRemission
dc.subjectRetinoblastoma
dc.titleRetinoblastoma: ten years experience at kanti children's hospital
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage579
oaire.citation.startPage576
relation.isJournalIssueOfPublication8d841c1c-a325-4c44-832d-306937ec270c
relation.isJournalIssueOfPublication.latestForDiscovery8d841c1c-a325-4c44-832d-306937ec270c
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
576-579.pdf
Size:
84.41 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections